The development and maintenance of pulmonary arterial hypertension (PAH) involves in multiple metabolic abnormalities, but the specific mechanism remains elusive. We aimed to further explore the underlying mechanism and look… Click to show full abstract
The development and maintenance of pulmonary arterial hypertension (PAH) involves in multiple metabolic abnormalities, but the specific mechanism remains elusive. We aimed to further explore the underlying mechanism and look for new biomarkers for diagnosis using metabolomics approach. Serum
               
Click one of the above tabs to view related content.